$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 50/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 50/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | A | 555.67 | 25,500 | 14,169,585 | 25,500 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 24.00 | 4,000 | 96,000 | 166 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 24.00 | 4,000 | 96,000 | 16,498 | 12.5 K to 16.5 K (+32.01 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | A | 555.67 | 28,900 | 16,058,863 | 28,900 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Option Exercise | A | 555.67 | 28,900 | 16,058,863 | 28,900 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | A | 555.67 | 3,800 | 2,111,546 | 3,800 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 52.03 | 1,921 | 99,950 | 6,866 | 4.9 K to 6.9 K (+38.85 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Option Exercise | A | 555.67 | 25,000 | 13,891,750 | 25,000 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Buy | M | 52.03 | 1,921 | 99,950 | 17,742 | 15.8 K to 17.7 K (+12.14 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 555.67 | 172,723 | 95,976,989 | 172,723 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 555.67 | 68,638 | 38,140,077 | 68,638 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 52.03 | 1,921 | 99,950 | 27,594 | 25.7 K to 27.6 K (+7.48 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 555.67 | 40,000 | 22,226,800 | 40,000 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | A | 555.67 | 40,000 | 22,226,800 | 40,000 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 52.03 | 1,921 | 99,950 | 1,921 | 0 to 1.9 K |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | A | 555.67 | 146,815 | 81,580,691 | 146,815 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Buy | M | 52.03 | 1,921 | 99,950 | 501,921 | 500 K to 501.9 K (+0.38 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | A | 555.67 | 92,123 | 51,189,987 | 92,123 |